Funding Sources

  1. Research Funding Program: Thales. Investing in knowledge society through the European Social Fund Union (European Social Fund – ESF) and Greek national funds through the Operational Program; Co-financed by the European “Education and Lifelong Learning" of the National Strategic Reference Framework (NSRF).
  2. Marie Skłodowska-Curie Research and Innovation Staff Exchange Funded by H2020, MSCA-RISE-2014 action[Grant Agreement number: 645756 — GLYCANC — H2020-MSCA-RISE-2014] for the Action: "Matrix glycans as multifunctional pathogenesis factors and therapeutic targets in cancer". Collaborators: Westfaelische Wilhelms University of Muenster, University of Reims Champagne-Ardenne, University of Insubria, University of Uppsala, National Center for Scientific Research “Demokritos”, Serend-IP GmBH, Fidia Farmaceutici SPA, Semmelweis Egyetem, Cairo University.
  3. "Νανοβιοτεχνολογική ενέσιμη εξωκυττάρια μήτρα ( ECM ) για αναγέννηση χόνδρου, εξατομικευμένη θεραπεία και ταυτοποίηση μεταβολιτών του «ατομικού» μικροβιώματος που εμπλέκονται στον εκφυλισμό των αρθρώσεων "ArthroMicroPerMed" Τ1ΕΔΚ-04567 της δράσης «ΕΡΕΥΝΩ-ΔΗΜΙΟΥΡΓΩ-ΚΑΙΝΟΤΟΜΩ», 2018-.
  4. MIZUTANI FOUNDATION FOR GLYCOSCIENCE, “THE 20TH RESEARCH GRANT 2013” “Biological roles of serglycin in breast cancer”.

We use cookies on our website. Some of them are essential for the operation of the site, while others help us to improve this site and the user experience (tracking cookies). You can decide for yourself whether you want to allow cookies or not. Please note that if you reject them, you may not be able to use all the functionalities of the site.